About Polyganics
Polyganics is a company based in Groningen (Netherlands) founded in 1999 was acquired by Collagen Matrix in October 2022. Polyganics offers products and services including RejuvaKnee™, Collagen Dental Membrane, and Dural Repair Products. Polyganics operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Groningen, Netherlands
- SectorsHealthcare
- EmailLocked
- PhoneLocked
- WebsiteLocked
- SocialLocked
- Legal Name Collagen Matrix Inc.
- Annual RevenueNot available
- Net ProfitNot available
- EBITDANot available
- Latest Funding Round$1.3 M (USD), Grant
May 13, 2020
- InvestorsEuropean Commission
& 2 more
- Employee CountNot available
- Acquired byCollagen Matrix
(Oct 05, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Polyganics
Polyganics offers a comprehensive portfolio of products and services, including RejuvaKnee™, Collagen Dental Membrane, and Dural Repair Products.
FDA-cleared device for meniscal repair and tissue regeneration.
Material for dental tissue healing and surgical support.
Bioresorbable solutions for dural closure in neurosurgery.
People of Polyganics
Unlock access to complete
Unlock access to complete
Funding Insights of Polyganics
Investors in Polyganics
Polyganics has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include European Commission, Collagen Matrix and SNN.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Financial support is provided for regional development in Northern Netherlands. | Locked | Locked | Locked | |
Institution of the European Union responsible for upholding the EU treaties | Locked | Locked | Locked | |
Collagen and mineral based medical devices | Locked | Locked | Locked |
Investor details for Polyganics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Polyganics
Investment portfolio details for Polyganics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Polyganics
Detailed financials for Polyganics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Polyganics Comparisons
Peer comparison for Polyganics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Polyganics
Polyganics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| Locked | Locked | Locked | Antibody-siRNA complexes are developed for cancer treatment. | |
| Locked | Locked | Locked | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| Locked | Locked | Locked | Yeast cells are genetically engineered to produce medicinal products. | |
| Locked | Locked | Locked | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| Locked | Locked | Locked | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed competitors of Polyganics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Polyganics
Complete news archive for Polyganics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polyganics
Polyganics was founded in 1999 and raised its 1st funding round 18 years after it was founded.
Polyganics is headquartered in Groningen, Netherlands. It is registered at Groningen, Groningen, Netherlands.
Polyganics is a medical technology company developing bioresorbable medical devices that facilitate natural tissue repair and regeneration based on their proprietary polymer technology. The companys platform allows the integration of polymer chemistry and engineering design to enable development of medical products with specific features such as porous scaffolds, tubes, sheets, sleeves or foams with tailor-made properties. The companys current product range covers ENT products, peripheral nerve repair and neurosurgery products and general surgery products. In 2014, Polyganics divested its ENT portfolio to Stryker.
Polyganics's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Polyganics offers RejuvaKnee™, Collagen Dental Membrane, and Dural Repair Products.
Polyganics has 3 investors. Key investors include European Commission, Collagen Matrix, and SNN.